Join Fund Library now and get free access to personalized features to help you manage your investments.
Sector Equity
Click for more information on Fundata’s ESG Grade
Click for more information on Fundata’s ESG Grade.
2013
Click for more information on Fundata’s FundGrade
|
NAVPS (11-19-2024) |
$52.70 |
|---|---|
| Change |
-$0.22
(-0.42%)
|
As at October 31, 2024
As at October 31, 2024
As at July 31, 2024
Loading...
Inception Return (July 23, 1996): 7.72%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -3.60% | -5.43% | 0.57% | 7.05% | 10.72% | 6.42% | 2.94% | 5.63% | 6.61% | 3.82% | 4.54% | 4.55% | 2.63% | 3.42% |
| Benchmark | 0.85% | 5.30% | 12.95% | 18.24% | 32.06% | 15.16% | 8.05% | 15.02% | 11.33% | 11.65% | 9.36% | 9.62% | 9.96% | 8.41% |
| Category Average | -0.55% | 1.27% | 9.75% | 16.69% | 32.21% | 20.51% | 3.93% | 10.09% | 11.90% | 11.88% | 11.02% | 12.06% | 11.03% | 11.60% |
| Category Rank | 173 / 200 | 183 / 195 | 180 / 191 | 149 / 189 | 167 / 189 | 122 / 156 | 88 / 147 | 92 / 132 | 96 / 127 | 101 / 116 | 89 / 101 | 81 / 86 | 84 / 86 | 76 / 78 |
| Quartile Ranking | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 |
| Return % | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 3.06% | 0.35% | 2.52% | 5.53% | 0.98% | -2.57% | 2.03% | 2.85% | 1.34% | 2.77% | -4.54% | -3.60% |
| Benchmark | 7.48% | 3.91% | 0.55% | 1.82% | 4.14% | -1.82% | 2.77% | -1.42% | 5.87% | 1.22% | 3.15% | 0.85% |
14.15% (June 2009)
-11.87% (October 2008)
| Return % | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 19.59% | 14.12% | -19.15% | 6.44% | 1.11% | 12.00% | 11.20% | -0.08% | -1.18% | 2.65% |
| Benchmark | 10.55% | -8.32% | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% |
| Category Average | 17.30% | 16.21% | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% |
| Quartile Ranking | 3 | 3 | 4 | 4 | 3 | 4 | 3 | 4 | 1 | 3 |
| Category Rank | 42/ 68 | 56/ 79 | 86/ 86 | 81/ 86 | 61/ 106 | 106/ 117 | 91/ 127 | 120/ 132 | 29/ 149 | 114/ 161 |
19.59% (2014)
-19.15% (2016)
| Name | Percent |
|---|---|
| US Equity | 80.92 |
| International Equity | 18.50 |
| Cash and Equivalents | 0.58 |
| Name | Percent |
|---|---|
| Healthcare | 96.10 |
| Exchange Traded Fund | 2.33 |
| Consumer Services | 0.99 |
| Cash and Cash Equivalent | 0.58 |
| Name | Percent |
|---|---|
| North America | 81.44 |
| Europe | 18.55 |
| Asia | 0.00 |
| Other | 0.01 |
| Name | Percent |
|---|---|
| UnitedHealth Group Inc | 10.74 |
| Eli Lilly and Co | 10.67 |
| Novo Nordisk A/S Cl B | 6.85 |
| AstraZeneca PLC | 6.45 |
| Abbvie Inc | 5.53 |
| Merck & Co Inc | 5.48 |
| Zoetis Inc Cl A | 5.14 |
| Thermo Fisher Scientific Inc | 4.01 |
| Boston Scientific Corp | 3.92 |
| Intuitive Surgical Inc | 3.61 |
CI Global Health Sciences Corporate Class (Series A shares)
Median
Other - Sector Equity
| Standard Deviation | 10.02% | 13.91% | 15.31% |
|---|---|---|---|
| Beta | 0.32% | 0.51% | 0.57% |
| Alpha | 0.01% | 0.01% | -0.01% |
| Rsquared | 0.18% | 0.33% | 0.23% |
| Sharpe | -0.01% | 0.37% | 0.19% |
| Sortino | 0.06% | 0.55% | 0.14% |
| Treynor | 0.00% | 0.10% | 0.05% |
| Tax Efficiency | 94.36% | 92.12% | 76.58% |
| Volatility |
|
|
|
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 10.43% | 10.02% | 13.91% | 15.31% |
| Beta | 0.17% | 0.32% | 0.51% | 0.57% |
| Alpha | 0.06% | 0.01% | 0.01% | -0.01% |
| Rsquared | 0.02% | 0.18% | 0.33% | 0.23% |
| Sharpe | 0.58% | -0.01% | 0.37% | 0.19% |
| Sortino | 1.14% | 0.06% | 0.55% | 0.14% |
| Treynor | 0.35% | 0.00% | 0.10% | 0.05% |
| Tax Efficiency | 100.00% | 94.36% | 92.12% | 76.58% |
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
| Start Date | July 23, 1996 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Corporation |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | $163 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| CIG1701 | ||
| CIG201 | ||
| CIG701 |
This fund’s objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio adviser believes would benefit from developments in the health sciences industry.
The portfolio advisor identifies companies that have the potential for strong growth in their industry and then considers the impact of economic trends. The portfolio advisor may use techniques such as fundamental analysis to assess growth potential. This means evaluating the financial condition and management of each company, its industry and the overall economy.
| Name | Start Date |
|---|---|
| Greg Quickmre | 06-14-2022 |
| Peter Hofstra | 06-14-2022 |
| Fund Manager | CI Global Asset Management |
|---|---|
| Advisor | CI Global Asset Management |
| Custodian | RBC Investor Services Trust (Canada) |
| Registrar | CI Global Asset Management |
| Distributor | - |
| Auditor | Ernst & Young LLP |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 50 |
| PAC Subsequent | 50 |
| SWP Allowed | Yes |
| SWP Min Balance | 5,000 |
| SWP Min Withdrawal | 50 |
| MER | 2.34% |
|---|---|
| Management Fee | 1.90% |
| Load | Choice of Front or No Load |
| FE Max | 5.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | 0.50% |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Join Fund Library now and get free access to personalized features to help you manage your investments.
Fund Library
